TY  - JOUR

T1  - A double blind, parallel, placebo controlled, dose ranging study on efficacy and safety of oral clodronate in cancer induced osteolysis measured by biochemical markers of bone resorption

JO  - Journal of Clinical Oncology

PY  - 2004/07/15

AU  - Brown JE

AU  - McCloskey E

AU  - Dewar JA

AU  - Body J-J

AU  - Cameron DA

AU  - Purohit OP-K

AU  - Harnett A

AU  - Tahtela R

AU  - Kurkilahti M

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1200/jco.2004.22.90140.8056

PB  - American Society of Clinical Oncology (ASCO)

VL  - 22

IS  - 14_suppl

SP  - 8056

EP  - 8056

Y2  - 2024/12/27

ER  -